Related Experiment Video
Updated: Jul 6, 2025
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Genetically light-enhanced immunotherapy mediated by a fluorinated reduction-sensitive delivery system.
Mengrui Su1, Junkai Wang1, Nana Zhao1
1State Key Laboratory of Chemical Resource Engineering, Key Lab of Biomedical Materials of Natural Macromolecules (Beijing University of Chemical Technology, Ministry of Education) and Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing, 100029, China.
A new gene delivery system enhances cancer treatment by combining photodynamic therapy and immunotherapy. This system effectively delivers therapeutic genes, boosting the immune response against tumors with minimal toxicity.
Area of Science:
- Biomaterials Science
- Cancer Therapy
- Gene Delivery
Background:
- Inefficient delivery platforms limit combined cancer therapy effectiveness.
- Improved multi-component delivery is crucial for synergistic cancer treatments.
Purpose of the Study:
- To develop a novel gene delivery system for combined cancer therapy.
- To enhance the delivery of immune and photodynamic agents to tumors.
Main Methods:
- Synthesized fluorine-containing degradable cationic polymers (SS-HPT-F) via amino-epoxy ring-opening.
- Engineered a combination plasmid (pMIP-3β-KR) for independent protein expression.
- Utilized the SS-HPT-F system for efficient gene delivery to tumor sites.
Main Results:
- Modified fluorinated chains significantly improved plasmid delivery efficiency.
- Delivered plasmid enabled independent expression of immune chemokine (MIP-3β) and photosensitive protein (KillerRed).
- Photodynamic therapy (PDT) induced cancer cell death and immune response, amplified by MIP-3β.
Conclusions:
- The SS-HPT-F/pMIP-3β-KR system provides an efficient platform for light-enhanced immunotherapy.
- This approach demonstrates synergistic effects of PDT and immunotherapy against tumors in vivo.
- The study presents the first gene delivery system achieving light-enhanced immunotherapy with no systemic toxicity.
